INTERNATIONAL PATENT: FRED HUTCHINSON CANCER CENTER FILES APPLICATION FOR "TCR T CELL THERAPY TARGETING HA-1"

GENEVA, Nov. 12 -- FRED HUTCHINSON CANCER CENTER (1100 Fairview Avenue NorthSeattle, Washington 98109) filed a patent application (PCT/US2025/027386) for "TCR T CELL THERAPY TARGETING HA-1" on May 01, 2025. With publication no. WO/2025/231299, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BLEAKLEY, Marie (8202 Ashworth Avenue NorthSeattle, Washington 98103)

Abstract: The present disclosure relates to HA-1-targeted T cell receptor (TCR) T cell therapy for treating hematological cancer, such as recurrent leukemia after h...